$DYN news
The latest DYN stock news: headlines, filings, AI summaries and sentiment for $DYN, updated around the clock.
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics, Inc. - 10-Q Filing
- Dow Jones Falls Sharply Due to Novartis' Failed Drug Trials
- Dyne Therapeutics Shares Drop Sharply Premarket Without Clear Catalyst
- Dyne Therapeutics Downgraded by J.P. Morgan Following Novartis Study Setback
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics, Inc. - 10-Q Filing
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics Shares Decline After Pricing $375 Million Public Offering
- Biggest Stock Movers Wednesday: SMCI, DYN, OKLO, PEGA
- Dyne Therapeutics Announces Upsized Public Offering of 18.3 Million Shares at $20.50 per Share
- Dyne Therapeutics Prices Upsized $375 Million Public Offering at $20.50 per Share
- Dyne Therapeutics Launches $300M Stock Offering; Shares Drop in After-Hours Trading
- FDA Accepts Dyne Therapeutics' BLA for Duchenne Muscular Dystrophy Treatment
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics Submits Biologics License Application for Duchenne Treatment
- Dyne Therapeutics, Inc. - 8-K Filing
- Dyne Therapeutics Stock Rises Amid $14 Million Stake Reduction by FCPM III Services B.V.
- FCPM III Services B.V. Sells $14 Million Stake in Dyne Therapeutics
- Saturn V Capital Sells $14M in Dyne Therapeutics Shares Despite Stock Rising 40%
- Dyne Therapeutics Announces Launch of Late-Stage Trial for Duchenne Muscular Dystrophy Therapy
- Dyne Therapeutics, Inc. - 10-Q Filing